Literature DB >> 23190533

Aberrant 3' oligoadenylation of spliceosomal U6 small nuclear RNA in poikiloderma with neutropenia.

Christine Hilcenko1, Paul J Simpson, Andrew J Finch, Frank R Bowler, Mark J Churcher, Li Jin, Len C Packman, Adam Shlien, Peter Campbell, Michael Kirwan, Inderjeet Dokal, Alan J Warren.   

Abstract

The recessive disorder poikiloderma with neutropenia (PN) is caused by mutations in the C16orf57 gene that encodes the highly conserved USB1 protein. Here, we present the 1.1 Å resolution crystal structure of human USB1, defining it as a member of the LigT-like superfamily of 2H phosphoesterases. We show that human USB1 is a distributive 3'-5' exoribonuclease that posttranscriptionally removes uridine and adenosine nucleosides from the 3' end of spliceosomal U6 small nuclear RNA (snRNA), directly catalyzing terminal 2', 3' cyclic phosphate formation. USB1 measures the appropriate length of the U6 oligo(U) tail by reading the position of a key adenine nucleotide (A102) and pausing 5 uridine residues downstream.We show that the 3' ends of U6 snRNA in PN patient lymphoblasts are elongated and unexpectedly carry nontemplated 3' oligo(A) tails that are characteristic of nuclear RNA surveillance targets. Thus, our study reveals a novel quality control pathway in which posttranscriptional 3'-end processing by USB1 protects U6 snRNA from targeting and destruction by the nuclear exosome. Our data implicate aberrant oligoadenylation of U6 snRNA in the pathogenesis of the leukemia predisposition disorder PN.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23190533     DOI: 10.1182/blood-2012-10-461491

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  29 in total

1.  Incomplete splicing of neutrophil-specific genes affects neutrophil development in a zebrafish model of poikiloderma with neutropenia.

Authors:  Prakash Patil; Tamayo Uechi; Naoya Kenmochi
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

Review 2.  The role of 3' end uridylation in RNA metabolism and cellular physiology.

Authors:  Dagmar Zigáčková; Štěpánka Vaňáčová
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-11-05       Impact factor: 6.237

Review 3.  New monogenic disorders identify more pathways to neutropenia: from the clinic to next-generation sequencing.

Authors:  Seth J Corey; Usua Oyarbide
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

4.  Poikiloderma with Neutropenia in Morocco: a Report of Four Cases.

Authors:  Ayoub Aglaguel; Houria Abdelghaffar; Fatima Ailal; Norddine Habti; Sebastian Hesse; Naschla Kohistani; Christoph Klein; Ahmed Aziz Bousfiha
Journal:  J Clin Immunol       Date:  2017-03-28       Impact factor: 8.317

5.  H/ACA small RNA dysfunctions in disease reveal key roles for noncoding RNA modifications in hematopoietic stem cell differentiation.

Authors:  Cristian Bellodi; Mary McMahon; Adrian Contreras; Dayle Juliano; Noam Kopmar; Tomoka Nakamura; David Maltby; Alma Burlingame; Sharon A Savage; Akiko Shimamura; Davide Ruggero
Journal:  Cell Rep       Date:  2013-05-23       Impact factor: 9.423

6.  Insights into Mutation Effect in Three Poikiloderma with Neutropenia Patients by Transcript Analysis and Disease Evolution of Reported Patients with the Same Pathogenic Variants.

Authors:  Elisa A Colombo; Nursel H Elcioglu; Claudio Graziano; Pamela Farinelli; Elisabetta Di Fede; Iria Neri; Elena Facchini; Mariangela Greco; Cristina Gervasini; Lidia Larizza
Journal:  J Clin Immunol       Date:  2018-05-16       Impact factor: 8.317

7.  PARN Modulates Y RNA Stability and Its 3'-End Formation.

Authors:  Siddharth Shukla; Roy Parker
Journal:  Mol Cell Biol       Date:  2017-09-26       Impact factor: 4.272

Review 8.  Noncoding RNA Surveillance: The Ends Justify the Means.

Authors:  Cedric Belair; Soyeong Sim; Sandra L Wolin
Journal:  Chem Rev       Date:  2017-10-12       Impact factor: 60.622

9.  Mutations in FAM111B cause hereditary fibrosing poikiloderma with tendon contracture, myopathy, and pulmonary fibrosis.

Authors:  Sandra Mercier; Sébastien Küry; Gasnat Shaboodien; Darren T Houniet; Nonhlanhla P Khumalo; Chantal Bou-Hanna; Nathalie Bodak; Valérie Cormier-Daire; Albert David; Laurence Faivre; Dominique Figarella-Branger; Romain K Gherardi; Elise Glen; Antoine Hamel; Christian Laboisse; Cédric Le Caignec; Pierre Lindenbaum; Armelle Magot; Arnold Munnich; Jean-Marie Mussini; Komala Pillay; Thahira Rahman; Richard Redon; Emmanuelle Salort-Campana; Mauro Santibanez-Koref; Christel Thauvin; Sébastien Barbarot; Bernard Keavney; Stéphane Bézieau; Bongani M Mayosi
Journal:  Am J Hum Genet       Date:  2013-11-21       Impact factor: 11.025

10.  Marked overlap of four genetic syndromes with dyskeratosis congenita confounds clinical diagnosis.

Authors:  Amanda J Walne; Laura Collopy; Shirleny Cardoso; Alicia Ellison; Vincent Plagnol; Canan Albayrak; Davut Albayrak; Sara Sebnem Kilic; Turkan Patıroglu; Haluk Akar; Keith Godfrey; Tina Carter; Makia Marafie; Ajay Vora; Mikael Sundin; Thomas Vulliamy; Hemanth Tummala; Inderjeet Dokal
Journal:  Haematologica       Date:  2016-09-09       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.